---
title: "BetterLife Pharma Launches $500,000 Private Placement to Advance LSD-Derived Neurology Drug"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282103310.md"
description: "BetterLife Pharma Launches $500,000 Private Placement to Advance LSD-Derived Neurology Drug"
datetime: "2026-04-08T22:19:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282103310.md)
  - [en](https://longbridge.com/en/news/282103310.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282103310.md)
---

# BetterLife Pharma Launches $500,000 Private Placement to Advance LSD-Derived Neurology Drug

BetterLife Pharma Launches $500,000 Private Placement to Advance LSD-Derived Neurology Drug

### Related Stocks

- [SAVU.US](https://longbridge.com/en/quote/SAVU.US.md)

## Related News & Research

- [BUZZ-Amylyx Pharma starts $350 mln equity offering to fund blood sugar drug](https://longbridge.com/en/news/296266391.md)
- [BetterLife Pharma Appoints Mahan Chehrenama, DO, as Chief Medical Officer | BETRF Stock News](https://longbridge.com/en/news/296354209.md)
- [AI isn’t close to curing cancer. This startup says it knows what it will take.](https://longbridge.com/en/news/296352961.md)
- [Royalty Pharma Locks in $100M Zealand Pharma Funding Pact for Blood Disorder Drug](https://longbridge.com/en/news/295829552.md)
- [Dicot Pharma submits EU clinical trial application for LIB-01 phase 2b study](https://longbridge.com/en/news/296068059.md)